The flavonoid quercetin inhibits titanium dioxide (TiO2)-induced chronic arthritis in mice

J Nutr Biochem. 2018 Mar:53:81-95. doi: 10.1016/j.jnutbio.2017.10.010. Epub 2017 Nov 5.

Abstract

Titanium dioxide (TiO2) is a common component of orthopedic prosthesis. However, prosthesis wear releases TiO2, which induces inflammation and osteolysis in peri-prosthetic tissues. Quercetin is a flavonoid widely present in human diet, which presents biological activities such as antinociceptive, anti-inflammatory and antioxidant effects. Therefore, the effect of intraperitoneal treatment with quercetin in TiO2-induced arthritis model was evaluated. In the first set of experiments, mice received injection of TiO2 (0.1-3 mg/knee joint) and articular mechanical hyperalgesia, edema and histopathology analysis were performed in a 30 days protocol. The dose of 3 mg of TiO2 showed the most harmful effect, and was chosen to the following experiments. Subsequently, mice received 3 mg of TiO2 followed by post-treatment with quercetin during 30 days. Quercetin (10-100 mg/kg) inhibited in a dose-dependent manner TiO2-induced knee joint mechanical hyperalgesia, edema and leukocyte recruitment and did not induce damage in major organs such as liver, kidney and stomach. The dose of 30 mg/kg was chosen for the subsequent analysis, and reduced histopathological changes such as leukocyte infiltration, vascular proliferation and synovial hyperplasia (pannus formation) on day 30 after TiO2 challenge. The protective analgesic and anti-inflammatory mechanisms of quercetin included the inhibition of TiO2-induced neutrophil and macrophage recruitment, proteoglycan degradation, oxidative stress, cytokine production (TNF-α, IL-1β, IL-6, and IL-10), COX-2 mRNA expression, and bone resorption as well as activation of Nrf2/HO-1 signaling pathway. These results demonstrate the potential therapeutic applicability of the dietary flavonoid quercetin to reduce pain and inflammatory damages associated with prosthesis wear process-induced arthritis.

Keywords: Arthritis; Cytokine; Hyperalgesia; Osteolysis; Quercetin; Quercetin (PubChem CID: 5,280,343); Titanium dioxide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / adverse effects
  • Analgesics, Non-Narcotic / pharmacology
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Arthritis, Experimental / chemically induced
  • Arthritis, Experimental / drug therapy*
  • Bone Resorption / chemically induced
  • Bone Resorption / drug therapy
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Cytokines / genetics
  • Cytokines / metabolism
  • Dose-Response Relationship, Drug
  • Edema / chemically induced
  • Edema / drug therapy
  • Hyperalgesia / chemically induced
  • Hyperalgesia / drug therapy
  • Injections, Intra-Articular
  • Injections, Intraperitoneal
  • Kidney / cytology
  • Kidney / drug effects
  • Knee Joint / drug effects*
  • Knee Joint / pathology
  • Liver / cytology
  • Liver / drug effects
  • Male
  • Mice
  • Oxidative Stress / drug effects
  • Quercetin / administration & dosage
  • Quercetin / adverse effects
  • Quercetin / pharmacology*
  • Titanium / administration & dosage
  • Titanium / toxicity

Substances

  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • titanium dioxide
  • Quercetin
  • Titanium
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2